Bedside Snapshot
- Normal (Adult)
- Adults 3.9–5.5 million/µL (textbook range, sex not stated); women 3.8–5.2 million/µL (same numbers in SI, ×10¹²/L). Lab- and sex-specific; pregnancy and children differ
- Critical Values
- No universal critical value: interpret with hemoglobin and hematocrit (typical critical Hgb <7 or >20 g/dL; lab-specific)
- High Suggests
- Dehydration or hemoconcentration (falsely high)
- Chronic hypoxia: COPD, sleep apnea, altitude, smoking
- Polycythemia vera (JAK2 positive, low EPO)
- EPO, testosterone or anabolic steroids
- Low Suggests
- Blood loss, acute or chronic
- Hemolysis
- Iron, B12 or folate deficiency; CKD
- Dilution from IV fluids or pregnancy
- Act Now If
- Hemorrhage with shock, or hemolysis with unstable vitals: control bleeding, large-bore access, send hemoglobin, hematocrit, type and screen; treat perfusion, not the count
- Watch Out For
- A normal count does not exclude anemia: it falls only after dilution, and microcytic thalassemia can show a normal or high count with low hemoglobin. Read it with hemoglobin
Reference & Critical Ranges
Lab-specific ranges: Each lab sets its own interval, based on its analyzer and its population. Check the range on your report first. The values below are typical.
Reference ranges
| Population | Conventional (million/µL) | SI (×10¹²/L) | Notes |
|---|---|---|---|
| Adults (Critical Care Transport; sex not stated) | 3.9–5.5 | 3.9–5.5 | Single adult range, sex not stated. Men run higher than women; the textbook range is not sex-specific, so use the range on your report |
| Adult women (Rosen's Table 121-1) | 3.8–5.2 | 3.8–5.2 | Rosen's Emergency Medicine Table 121-1; lab-specific |
| Pregnancy | — | — | Lower as plasma volume expands; no count range given. Judge anemia by trimester hemoglobin cutoffs from the CDC 1998 recommendations |
| Infants (birth to <1 year) | 2.90–5.16 | 2.90–5.16 | Both sexes; CALIPER 2020 (0 to <1 year). Newborn counts in the first days run higher than this band; use the lab's neonatal interval |
| Children (1 to ≤14 years), boys | 4.10–5.08 | 4.10–5.08 | CALIPER 2020 |
| Children (1 to <14 years), girls | 3.94–4.97 | 3.94–4.97 | CALIPER 2020 |
| Adolescents (14 to <21 years), boys | 4.26–5.60 | 4.26–5.60 | Sex difference appears after puberty; CALIPER 2020 |
| Adolescents (14 to <21 years), girls | 3.95–5.13 | 3.95–5.13 | CALIPER 2020 |
Severity & critical values
| Level | Conventional (million/µL) | What it means |
|---|---|---|
| Below range | Below the limit that applies: <3.9 on the single adult range; <3.8 for women | Possible anemia; confirm with hemoglobin and hematocrit |
| Above range | Above the limit that applies: >5.5 on the single adult range; >5.2 for women | Erythrocytosis: relative (plasma loss) or absolute (marrow or EPO driven) |
| Critical | None universal | Act on hemoglobin and hematocrit critical values instead |
Critical values: There is no universal critical RBC count. Act on hemoglobin (typical critical <7 or >20 g/dL) and hematocrit (typical critical <20% or >60%). Both are typical, and both are lab-specific. A lab critical value is a call-back threshold. It is not a transfusion trigger. Clinical status and current guidelines drive transfusion decisions.
Conversion: Same number, two labels. Million/µL and ×10¹²/L are identical.
Mentzer index (screening only)
MCV (fL) ÷ RBC (million/µL)
Normal values sit at about 13 or higher. Below 13, the index favors thalassemia trait over iron deficiency. See Interpretation.
Causes of Abnormal Results
High (Erythrocytosis, RBC above range)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Relative (plasma loss) | Dehydration, vomiting, diarrhea, diuretics, burns | Hemoconcentration; count and hemoglobin fall after rehydration |
| Primary marrow (polycythemia vera) | JAK2-positive myeloproliferative neoplasm | Low EPO; often raised hemoglobin, hematocrit and platelets; thrombosis |
| Secondary, hypoxic | COPD, sleep apnea, cor pulmonale, congenital heart disease with right-to-left shunt, pulmonary fibrosis, high altitude | Low SpO₂; high EPO |
| Secondary, EPO-mediated | Renal cysts or tumors, renal artery stenosis, EPO-secreting tumors | High EPO without hypoxia; flank mass or hypertension |
| Exogenous | Testosterone, anabolic steroids, erythropoietin; cigarette smoking (chronic CO and hypoxia) | Medication or drug history; smoker's profile |
Hyperviscosity and thrombosis: Think viscosity, then clots. A high count raises both. Headache, visual change, dizziness or focal neurologic signs with a high count? That needs urgent evaluation, not a routine recheck.
Low (RBC below range)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Blood loss | Trauma, GI bleeding, surgical loss, heavy menstrual bleeding | Tachycardia, hypotension, melena; count lags acute loss |
| Hemolysis | Autoimmune, G6PD deficiency, spherocytosis, sickle cell, microangiopathic hemolysis, mechanical valves, transfusion reaction; hypersplenism (sequestration) | Raised reticulocytes; jaundice; dark urine |
| Decreased production | Iron, B12 or folate deficiency; chronic kidney disease (low EPO); anemia of chronic disease or inflammation; hypothyroidism; marrow failure, leukemia, myelodysplasia, marrow infiltration | Low reticulocytes; MCV pattern guides cause |
| Dilution | IV fluids, overhydration, pregnancy | No true deficit; recheck after equilibration |
| Medications | Chemotherapy, chloramphenicol, methyldopa, NSAIDs (GI loss), quinidine | Recent drug start; check medication list |
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Check for hemoconcentration, tourniquet time, clotted or clumped samples. Repeat when euvolemic or on a clean draw.
- How sick is the patient? Perfusion, bleeding, SpO₂ and neurologic status come first. The count doesn't run the resuscitation.
- Acute or chronic? Compare with prior counts. Early in acute blood loss, plasma and red cells leave together, so the count still looks normal.
- Calculate indices. Read the count with hemoglobin, hematocrit, MCV and the Mentzer index (MCV ÷ RBC).
- Classify. High count: relative or absolute, then EPO. Low count: loss, destruction or production, using reticulocytes. For the red cell size pattern, see MCV.
- Escalate or refer. Urgent care for bleeding or shock. Hematology referral for an unexplained high count (JAK2 testing for polycythemia vera).
Pattern table
| Pattern | Suggests |
|---|---|
| High count, high hemoglobin and hematocrit, low EPO | Polycythemia vera (confirm JAK2) |
| High count, high hemoglobin and hematocrit, high EPO | Hypoxic or EPO-driven secondary cause; exogenous EPO or testosterone |
| High count, normal hemoglobin and hematocrit | Relative (dehydration or plasma loss); repeat when euvolemic |
| Normal or high count, low hemoglobin, low MCV, Mentzer index below 13 | Thalassemia trait; confirm with hemoglobin electrophoresis |
| Low count, low reticulocytes | Production problem: iron, B12 or folate, kidney disease, marrow failure |
| Low count, high reticulocytes | Blood loss recovery or hemolysis |
The Mentzer index is a screen, not a verdict. It dates from a 1973 derivation. Values close to 13 need hemoglobin electrophoresis or iron studies, per local protocol.
Polycythemia workup: Rule out hemoconcentration first. Then measure EPO and test for JAK2. The WHO major criterion is hemoglobin above 16.5 g/dL in men or above 16 g/dL in women, or hematocrit above 49% in men or above 48% in women. Those numbers don't diagnose on their own. The diagnosis also needs a JAK2 mutation and a bone marrow or low-EPO criterion.
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Infants and children | Age-specific ranges; boys and girls differ slightly even in childhood per CALIPER 2020, and more after puberty | Use age and sex bands in the Reference table; judge a count against that band |
| Pregnancy | Plasma volume expands more than red cell mass, so count and hemoglobin fall | Use trimester hemoglobin cutoffs of 11, 10.5 and 11 g/dL from the CDC 1998 recommendations as anemia thresholds rather than the non-pregnant count |
| Older adults | Slight decline in some people; no separate geriatric count range used here | Interpret with hemoglobin, symptoms and trend |
| CKD and dialysis | Low EPO lowers the count; erythropoiesis-stimulating agents raise it | Target set by nephrology; a rising count on ESA therapy needs review |
| Altitude and athletes | Chronic altitude raises the count; EPO and testosterone doping raise it | Check hydration and medication history before calling polycythemia |
Pregnancy and altitude: Both move the count for physiologic reasons, so the adult range is the wrong ruler. Use the cutoff for that population.
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Prolonged tourniquet or fist clenching | False + | Local hemoconcentration | Limit tourniquet time; redraw if prolonged |
| Clotted sample | False − | Cells trapped in clot | Redraw; check the tube for clot |
| Delayed analysis | Changes MCV and hematocrit | Cell swelling in stored blood (raised MCV and hematocrit) | Analyze within the lab's stability window |
Physiologic and biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Dehydration or IV fluid | False + / False − | Plasma volume changes | Note hydration status; recheck after equilibration |
| Cold agglutinins or EDTA-dependent clumping | False − | Cells clump and are undercounted | Smear review; warm the sample and repeat per lab protocol |
| Smoking, altitude | ↑ | Chronic hypoxia drives EPO | Interpret with SpO₂ and smoking history |
| Recent blood donation or hemorrhage | ↓ | Red cell mass lost | Interpret with the trend, not one value |
Medications & supplements
- Testosterone, anabolic steroids, EPO: push the count up (↑)
- Chemotherapy, chloramphenicol, NSAIDs: can pull the count down (↓)
Common misinterpretations
- A high count after dehydration is not polycythemia. Repeat it after rehydration.
- A normal count doesn't rule out anemia. Check the hemoglobin.
- High count, low hemoglobin? That's not polycythemia. Think microcytic thalassemia trait.
- Pediatric counts follow age bands. The adult range doesn't apply.
Physiology & Test Basics
What it measures
The RBC count is the number of red cells in one microliter of whole blood. On this page it is the cell-number part of the CBC. You read it alongside hemoglobin, hematocrit and the RBC indices (MCV, MCH, MCHC). Their own pages cover those indices.
Physiology & regulation
- Function: Red cells carry oxygen on hemoglobin. They bring carbon dioxide back to the lungs.
- Production: The marrow makes them, a process called erythropoiesis. Kidney EPO drives it when tissues are short on oxygen (hypoxia).
- Requirements: Iron, B12 and folate are the raw materials. Short on any of them, production isn't normal.
- Destruction: The spleen and liver clear out old and damaged cells.
How it is measured
The sample goes in a lavender (K₂EDTA) top, whole blood, mixed gently. An automated hematology analyzer counts it, usually as part of the CBC. Results come back with hemoglobin, hematocrit and indices. Analyze promptly. Delay changes the MCV and the hematocrit.
Why it matters
The count helps you tell anemia from polycythemia. Add MCV and reticulocytes, and the cause narrows. In emergency care, hemoglobin leads and the count follows. A high count with symptoms, though, points to thrombosis risk.
RBC vs hemoglobin vs hematocrit: The RBC count is the number of cells. Hemoglobin is the oxygen-carrying protein, and it's the primary anemia criterion. Hematocrit is the share of blood volume that is red cells.
Clinical Pearls
Count can mislead in thalassemia: Microcytic thalassemia trait can show a normal or high RBC count with low hemoglobin, so the count can fool you. Hemoglobin defines anemia, not the count.
Acute bleeding lags: Early in a bleed, plasma and red cells leave together. So a normal count doesn't exclude major blood loss. The count falls as fluid shifts or IV fluid dilutes the blood. Trend it over hours.
EMS: a high count is often dehydration: Heat, vomiting or diarrhea push the count up. Document the fluids given. Then expect the count to fall after rehydration. Don't jump to polycythemia.
Transport and ED monitoring: IV fluids dilute the count and the hemoglobin. Compare the trend and the bleeding picture. Don't judge a post-fluid number on its own.
Reticulocytes split low counts: Reticulocytes sort the low counts. High reticulocytes with a low count point to blood loss or hemolysis. Low reticulocytes point to production failure. Whenever the count is low, ask for reticulocytes.
Polycythemia vera thrombosis: The usual phlebotomy goal in polycythemia vera is a hematocrit below 45% (CYTO-PV). Low-dose aspirin is commonly used for thrombosis prevention unless contraindicated. Hematology makes the call.
References
- MedlinePlus, U.S. National Library of Medicine. (2026). Red blood cell (RBC) count (medical encyclopedia; review date February 27, 2026). https://medlineplus.gov/ency/article/003644.htm
- Tahmasebi, H., Higgins, V., Bohn, M. K., Hall, A., & Adeli, K. (2020). CALIPER hematology reference standards (I). American Journal of Clinical Pathology, 154(3), 330–341. https://doi.org/10.1093/ajcp/aqaa059
- Gulati, G., Uppal, G., & Gong, J. (2022). Unreliable automated complete blood count results: Causes, recognition, and resolution. Annals of Laboratory Medicine, 42(5), 515–530. https://doi.org/10.3343/alm.2022.42.5.515
- Tefferi, A., & Barbui, T. (2023). Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 98(9), 1465–1487. https://doi.org/10.1002/ajh.27002
- Marchioli, R., et al. (2013). Cardiovascular events and intensity of treatment in polycythemia vera (CYTO-PV). New England Journal of Medicine, 368(1), 22–33. (landmark trial) https://doi.org/10.1056/NEJMoa1208500
- Mentzer, W. C. (1973). Differentiation of iron deficiency from thalassaemia trait. The Lancet, 1(7808), 882. (landmark derivation paper) https://doi.org/10.1016/s0140-6736(73)91446-3
- Centers for Disease Control and Prevention. (1998). Recommendations to prevent and control iron deficiency in the United States. MMWR Recommendations and Reports, 47(RR-3), 1–29. https://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.